<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04012658</url>
  </required_header>
  <id_info>
    <org_study_id>MRCTA,ECFAH OF FMU[2019]197</org_study_id>
    <nct_id>NCT04012658</nct_id>
  </id_info>
  <brief_title>A Registered Cohort Study on Wilson's Disease</brief_title>
  <official_title>A Registered Cohort Study on Wilson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wan-Jin Chen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Fujian Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the clinical spectrum and natural progression of
      Wilson's Disease in a prospective multicenter natural history study, to assess the clinical,
      genetic, epigenetic features and biomarkers of patients with Wilson's Disease to optimize
      clinical management.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">December 2049</completion_date>
  <primary_completion_date type="Anticipated">December 2039</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The change of Unified Wilson's Disease Rating Scale (UWDRS)</measure>
    <time_frame>Up to 30years</time_frame>
    <description>Disease severity will be assessed by application of the Unified Wilson's Disease Rating Scale (UWDRS), a clinical rating scale consists of three subscales. Higher UWDRS total scores indicate more severe disease.</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Wilson's Disease</condition>
  <arm_group>
    <arm_group_label>Patients with the genetic diagnosis of Wilson's Disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Asymptomatic Wilson's Disease carriers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Relatives of Wilson's Disease patients or carriers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Unrelated healthy controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Asymptomatic Wilson's Disease carriers</arm_group_label>
    <arm_group_label>Patients with the genetic diagnosis of Wilson's Disease</arm_group_label>
    <arm_group_label>Relatives of Wilson's Disease patients or carriers</arm_group_label>
    <arm_group_label>Unrelated healthy controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Wilson's Disease are diagnosed by the clinical and/or genetic features
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with the genetic diagnosis of Wilson's Disease

          -  Asymptomatic Wilson's Disease carriers

          -  Relatives of Wilson's Disease patients or carriers

          -  Unrelated healthy controls

          -  Participants or Parent(s)/legal guardian(s) willing and able to complete the informed
             consent process

        Exclusion Criteria:

        * Participants are unable to comply with study procedures and visit schedule
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jin He, MD</last_name>
    <phone>86-0591-87982772</phone>
    <email>hejinfjmu@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yi Lin, MD.PhD</last_name>
    <phone>8613615039153</phone>
    <email>linyi7811@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Affiliated Hospital of Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin He, MD</last_name>
      <phone_ext>+1386061359</phone_ext>
    </contact>
    <contact_backup>
      <phone>86-0591-87982772</phone>
      <email>hejinfjmu@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Wan-Jin Chen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ning Wanf, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 6, 2019</study_first_submitted>
  <study_first_submitted_qc>July 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>September 19, 2019</last_update_submitted>
  <last_update_submitted_qc>September 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Fujian Medical University</investigator_affiliation>
    <investigator_full_name>Wan-Jin Chen</investigator_full_name>
    <investigator_title>The Vice-Director for the Department of Neurology</investigator_title>
  </responsible_party>
  <keyword>Wilson's Disease</keyword>
  <keyword>Nature history</keyword>
  <keyword>Genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatolenticular Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

